By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lipocine Inc. 

675 Arapeen Drive
Suite 202
Salt Lake City  Utah  84108  U.S.A.
Phone: 801-994-7383 Fax:


Company News
Lipocine Inc. (LPCN) To Present At 27th Annual Piper Jaffray Healthcare Conference 11/24/2015 11:42:41 AM
Lipocine Inc. (LPCN) Adopts Stockholder Rights Plan 11/16/2015 7:55:37 AM
Lipocine Inc. (LPCN) Announces PDUFA Goal Date For LPCN 1021 NDA 11/13/2015 10:28:19 AM
Lipocine Inc. (LPCN) Announces Financial And Operational Results For The Third Quarter of 2015 11/13/2015 10:18:50 AM
Lipocine Inc. (LPCN) Announces Presentation Of LPCN 1021 Clinical Data At 21st Annual SMSNA Meeting 11/12/2015 9:27:00 AM
Clarus Therapeutics Seeks Injunction Against The Marketing Of Lipocine Inc. (LPCN)'s Oral Product For Testosterone Replacement Therapy (LPCN 1021) 11/3/2015 7:42:50 AM
FDA Accepts For Filing Lipocine Inc. (LPCN)’s New Drug Application For Its Oral Testosterone Replacement Product Candidate, LPCN 1021 10/30/2015 9:46:04 AM
Lipocine Inc. (LPCN) Announces First Subject Dosed In Multi-Dose PK Study For Its Oral Product Candidate For The Prevention Of Pre-Term Birth 9/28/2015 7:53:38 AM
Lipocine Inc. (LPCN) To Present At Ladenburg Thalmann 2015 Healthcare Conference 9/22/2015 8:42:32 AM
Lipocine Inc. (LPCN) Submits New Drug Application To FDA For Its Oral Testosterone Replacement Product Candidate, LPCN 1021 8/31/2015 7:22:51 AM